ARCHIVES

In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC

This article is from The Cancer Letter archive.

Vol. 25 No. 26 | July 2, 1999

Download PDF Visit The Full Archive

Related Articles

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

November 1, 2012

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

FDA cancer therapeutics review split among three units in reorganization.

October 10, 2003

After ODAC: Questions On ESA Claims, Advertising, Reimbursement Gain Urgency.

May 18, 2007

Moloney Out As Viral Oncology Chief, Names “Acting Assistant Director” Of NCI By Upton

January 6, 1978